Navigation Links
Anti-Cancer Drug Shows Early Promise in Pulmonary Hypertension

nger keep up. Less and less blood reaches the lungs, the heart enlarges to try to overcome the pressure, and damage to the overworked heart accumulates.

Although treatment for pulmonary hypertension has improved, long-term survival, even with therapy, is disappointing, similar to that for lung cancer. Because sorafenib inhibits the chemical signals that can trigger both cellular proliferation and new blood vessel growth, Gomberg-Maitland and colleagues suspected it might slow the growth and thickening of the pulmonary artery walls.

To test this theory they treated rats at high risk for pulmonary hypertension with sorafenib. The researchers studied five groups of rats. One group stayed in normal cages and received no medication. The other four groups spent three weeks in a low-oxygen environment–about half the normal level–which can trigger pulmonary hypertension. Rats in the reduced-oxygen chambers received: no medication, a drug called SU5416 (well known to cause severe pulmonary hypertension in this setting), SU5416 plus sorafenib, or sorafenib alone.

As expected, the unmedicated rats in a low-oxygen environment had mildly elevated pulmonary artery pressures after three weeks and those that received SU5416 developed severe pulmonary hypertension. But, those that received sorafenib or sorafenib plus S5416, had negligible pressure increases. Sorafenib appeared not only to counteract the effects of the low-oxygen environment but also to prevent the additional damage caused by SU5416.

"This was an encouraging sign," said Gomberg-Maitland. This is "one of the best models we have for this disease," she said.

The side effects of the drug in humans have been relatively mild. The most common adverse effects are: rashes of the face and arms or hands and feet, mild diarrhea, and fatigue.

Source-Newswise
RM
'"/>




Page: 1 2

Related medicine news :

1. Anti-Cancer Drug Restores Normal Cell Growth
2. FDA Approves Anti-Cancer Cell Drug - Zevalin
3. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
4. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
5. Antidepressant Drug Found To Have Anti-Cancer Effects
6. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Exercise Has An Anti-Cancer Effect
11. A New Anti-Cancer Drug Keeps Resistance Out
Post Your Comments:
(Date:9/5/2008)...ay patients taking meds on Web site shouldn,t over...pt. 5 (HealthDay News) -- The U.S. Food and Drug A...drugs being evaluated for potential safety issues,...on a quarterly report, it means we have begun anal...m that requires further evaluation," Dr. Gerald Da...
(Date:9/5/2008)...g cancer risk prediction models are enhanced by ta...uring DNA repair capacity, according to research t...exas M. D. Anderson Cancer Center in two complemen...ancer Prevention Research . , In the first study...unique results based on increased exposure to cert...
(Date:9/4/2008)...S, N.Y., Sept. 5 /PRNewswire/ -- A groundbreaking ...ental and emotional status of,men, their shorter l...,medical needs will take place Wednesday, Septembe...he auspices of members of the Westchester,medical ...rianne J. Legato,M.D. and Lionel Tiger, Ph.D., D...
(Date:9/4/2008)...Y, September 5, 2008Private Medicare Advantage (MA...per enrollee in 2008 compared to what the same enr...fee-for-service program, according to a new report...reductions to MA plans mandated by the Medicare Im...(MIPPA) scheduled to take effect beginning in 201...
Breaking Medicine News(10 mins):Health News:FDA to List Drugs Under Review for Safety Issues 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2
...g to impose higher premiums on women who have not ... approached government regulators in this regard a...RCA1 and BRCA2 genetic mutations,// which play a h...nd ovarian cancers. Currently, the insurance indu...
...bled gay men contact in Hong Kong has been in a wa...ding to a latest report. // Government health off... and November 2005, had HIV with similar gene sequ...ning Post reported. The discovery was made when a...
...ine, labor unions are pushing Wal-Mart against a W... // Although it appears that the unions are doing...eir lot, there appears more to it than what meets ...major tussle between the vehemently anti-union com...
...tal health court, the first one of its kind in the...ve to pick // out sober and non violent defendants... to languish in the jails. U.S. House Speaker Den...fund to help with administration of Kane County Tr...
Other Medicine News:
(Date:9/4/2008)...iral activity and favorable safety ... 4 /- Idenix,Pharmaceutical...any engaged,in the discovery and development of dr...ectious diseases, today announced that it has comp..., a non-nucleoside reverse,transcriptase inhibitor...
(Date:9/3/2008)...Children Studied. Wrong,Conclusions Reached., NIX...rs for Disease,Control and Prevention (CDC) study ... MMR vaccine and autism. The National Autism Assoc...l the growing public concern over a,vaccine-autism...g design,and methodology., For years, parents hav...
(Date:9/3/2008)... Disease Awareness Month, CHARLOTTESVILLE, Va., S...LC, a clinical-stage drug-development company comm...edical needs, announced today that it has begun,to... its lead drug,candidate trans sodium crocetinate ...inicaltrials.gov Website, is investigating TSC as ...
(Date:9/3/2008)... 3 Plans with FDA, PRINCETON, N.J., Sept. 3 /PRNe...ay that it successfully completed two key clinical...nnovative low-dose, once-weekly,contraceptive pat...oduct,code AG-200-15. The Phase 2b safety and effi...f ovulation suppression, cycle control and safety....
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 1PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 2PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 3PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 4PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 5Sleep Apnea Screening Cuts Surgical Complications 17520 1Sleep Apnea Screening Cuts Surgical Complications 17520 2Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 1Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 2Ceregene Announces Two Key Additions to Leadership Team 4799 1Ceregene Announces Two Key Additions to Leadership Team 4799 2Ceregene Announces Two Key Additions to Leadership Team 4799 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: